Repligen | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Agilent USD 899M 18M 2025-01
Align Technology USD 680.11M 16.83M 2025-03
Bio Techne USD 196.58M 8.66M 2024-12
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Bruker USD 391.2M 102.1M 2025-03
Charles River Laboratories USD 340.1M 20.42M 2025-03
Danaher USD 3.53B 364M 2025-03
Dentsply International USD 466M 11M 2025-03
Exact Sciences USD 500.55M 71.25M 2025-03
General Electric USD 3.73B 102M 2025-03
Henry Schein USD 1000M 7M 2025-03
Illumina USD 683M 45M 2025-03
IQVIA Holdings USD 1.3B 80M 2025-03
Mettler Toledo International USD 525.88M 113.44M 2025-03
Myriad Genetics USD 134.2M 16.7M 2025-03
Pfizer USD 11.12B 987M 2025-03
Repligen USD 90.76M 10.44M 2025-03
Revvity USD 375.55M 36.74M 2025-03
Standard Biotools USD 21.9M 1.36M 2024-12
Thermo Fisher Scientific USD 4.31B 514M 2025-03
Waters USD 384.96M 139.24M 2025-03
West Pharmaceutical Services USD 231.9M 41.7M 2025-03



Repligen Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.